The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bayer Health; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Medac; Santorin-Aventis
Consulting or Advisory Role - Astellas Pharma; Bayer Health; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Medac; Santorin-Aventis
Research Funding - Astellas Pharma; Bayer Health; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Medac; Santorin-Aventis
Travel, Accommodations, Expenses - Astellas Pharma; Bayer Health; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Medac; Santorin-Aventis
Abiraterone acetate (AA) plus prednisone (P) 5 mg QD in metastatic castration-naïve prostate cancer (mCNPC): Detailed safety analyses from the LATITUDE phase 3 trial.
 
Karim Fizazi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; CureVac; Genentech; Janssen; Orion; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; CureVac; Genentech; Janssen; Orion; Sanofi
 
Namphuong Tran
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Luis Enrique Fein
Consulting or Advisory Role - Merck; Novartis; Pfizer; Roche
Speakers' Bureau - MSD; Novartis; Roche
Research Funding - Abbvie; Janssen; Merck; MSD; Novartis; Pfizer; Roche
 
Nobuaki Matsubara
Consulting or Advisory Role - Janssen; Sanofi
Research Funding - Bayer Yakuhin (Inst); Chugai Pharma (Inst); Janssen (Inst); MSD (Inst)
 
Anders Bjartell
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Janssen
 
Luca Galli
No Relationships to Disclose
 
Jae-Lyun Lee
Honoraria - Astellas Pharma; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Eisai
Research Funding - Exelixis; Janssen; Novartis; Pfizer
 
Danish Mazhar
No Relationships to Disclose
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Roche Canada (Inst); Sanofi (Inst)
 
David Olmos
No Relationships to Disclose
 
Henrik Suttmann
No Relationships to Disclose
 
Qing Zou
No Relationships to Disclose
 
Susan Li
Employment - Janssen Research & Development
 
Jason L. Martin
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Youn C. Park
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Giri Sulur
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Kris Deprince
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Peter De Porre
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)